ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)

Phase 3

Recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: Standard Buprenorphine Dose
Drug: High Dose Buprenorphine

First Posted Date: 2022-10-21

Last Posted Date: 2024-03-25

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 140

Registration Number: NCT05589181

Locations: 🇺🇸
UCLA Olive View, Sylmar, California, United States
🇺🇸
Barnes Jewish Hospital Emergency Department, Saint Louis, Missouri, United States
🇺🇸
Mount Sinai Hospital, New York, New York, United States

and more 2 locations

Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders

Not Applicable

Conditions: Eating Disorder

Interventions: Behavioral: Parent Education and Patient Coaching
Behavioral: Parent Coaching and Patient Education

First Posted Date: 2022-09-30

Last Posted Date: 2024-07-18

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 70

Registration Number: NCT05562258

Locations: 🇺🇸
Department of Psychiatry, Eating and Weight Disorders Program, New York, New York, United States

TEEN HEED: An Adolescent Diabetes Prevention Intervention Incorporating Novel Mobile Health Technologies

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Text messaging
Behavioral: Virtual workshop

First Posted Date: 2022-09-29

Last Posted Date: 2023-12-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 54

Registration Number: NCT05560386

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Early Phase 1

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Iberdomide
Drug: Elotuzumab
Drug: Dexamethasone

First Posted Date: 2022-09-29

Last Posted Date: 2024-12-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 7

Registration Number: NCT05560399

Locations: 🇺🇸
Icahn School of Medicine, New York, New York, United States

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

Not Applicable

Recruiting

Conditions: Anorexia Nervosa

Interventions: Device: Sham
Device: taVNS

First Posted Date: 2022-09-26

Last Posted Date: 2024-07-26

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 30

Registration Number: NCT05554172

Locations: 🇺🇸
Department of Psychiatry, Eating and Weight Disorders Program, New York, New York, United States

Vancomycin Study in Multiple Sclerosis (MS)

Phase 1

Recruiting

Conditions: Multiple Sclerosis

Interventions: Drug: Vancomycin
Drug: Placebo

First Posted Date: 2022-09-14

Last Posted Date: 2024-03-22

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 12

Registration Number: NCT05539729

Locations: 🇺🇸
Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, New York, United States

Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation

Not Applicable

Recruiting

Conditions: Transcranial Ultrasound With Sonolucent Cranioplasty
TUSC

Interventions: Device: ClearFit implant
Procedure: transcranial ultrasonography through sonolucent cranioplasty

First Posted Date: 2022-09-13

Last Posted Date: 2024-05-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT05538286

Locations: 🇺🇸
Mount Sinai Health System, New York, New York, United States

Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study

Completed

Conditions: Pregnancy
Hyperlipidemia

Interventions: Diagnostic Test: Lipid panel

First Posted Date: 2022-09-10

Last Posted Date: 2024-11-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 111

Registration Number: NCT05535660

Locations: 🇺🇸
Mount Sinai OBGYN Faculty Practice Associates, New York, New York, United States

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Phase 2

Recruiting

Conditions: Sickle Cell Disease

Interventions: Drug: Placebo
Drug: Dronabinol

First Posted Date: 2022-08-29

Last Posted Date: 2024-07-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 60

Registration Number: NCT05519111

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia

Not Applicable

Completed

Conditions: Alzheimer's Disease

Interventions: Device: Active lighting intervention
Device: Control lighting intervention

First Posted Date: 2022-08-29

Last Posted Date: 2023-06-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 14

Registration Number: NCT05519137

Locations: 🇺🇸
Light and Health Research Center, Menands, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy